Cisplatin Nephrotoxicity: A Review

2007/08/01 by Xin Yao, Kessarin Panichpisal, Neil Kurtzman +2 · 30 citations
Medicine · #Chemotherapy-induced organ toxicity mitigation #Chemotherapy-induced cardiotoxicity and mitigation #Nephrotoxicity and Medicinal Plants

paper · doi:10.1097/maj.0b013e31812dfe1e

Cited by

• Cisplatin in cancer therapy: Molecular mechanisms of action
• Copper metabolism as a unique vulnerability in cancer
• Advances in anticancer applications of platinum(II) complexes of dithiocarbamates
• Inflammation and tumor progression: signaling pathways and targeted intervention
• RETRACTED: Nephroprotective effect of AT-MSCs against cisplatin-induced EMT is improved by azilsartan via attenuating oxidative stress and TGF-β/Smad signaling
• Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity. [europepmc]
• Transplantation of bone marrow-derived MSCs improves cisplatinum-induced renal injury through paracrine mechanisms. [europepmc]
• Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. [europepmc]
• Nanocarriers for delivery of platinum anticancer drugs. [europepmc]
• Klotho has dual protective effects on cisplatin-induced acute kidney injury. [europepmc]
• Cisplatin in cancer therapy: molecular mechanisms of action. [europepmc]
• An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. [europepmc]
• Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy. [europepmc]
• X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism. [europepmc]
• An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures. [europepmc]
• Protective effects of apigenin and myricetin against cisplatin-induced nephrotoxicity in mice. [europepmc]
• Cisplatin-induced renal inflammation is ameliorated by cilastatin nephroprotection. [europepmc]
• The Protective Effects of p-Coumaric Acid on Acute Liver and Kidney Damages Induced by Cisplatin. [europepmc]
• Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges. [europepmc]
• Kidney-on-a-chip: untapped opportunities. [europepmc]
• The protective effects of maltol on cisplatin-induced nephrotoxicity through the AMPK-mediated PI3K/Akt and p53 signaling pathways. [europepmc]
• Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity. [europepmc]
• Evaluation of cisplatin-induced injury in human kidney organoids. [europepmc]
• Platinum complexes of curcumin delivered by dual-responsive polymeric nanoparticles improve chemotherapeutic efficacy based on the enhanced anti-metastasis activity and reduce side effects. [europepmc]
• Copper metabolism as a unique vulnerability in cancer. [europepmc]
• Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy. [europepmc]
• Inflammation and tumor progression: signaling pathways and targeted intervention. [europepmc]
• Cisplatin chemotherapy and renal function. [europepmc]
• Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoids. [europepmc]
• Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases. [europepmc]